107 related articles for article (PubMed ID: 7778537)
1. Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Québec Cardiovascular Study).
Lamarche B; Després JP; Moorjani S; Cantin B; Dagenais GR; Lupien PJ
Am J Cardiol; 1995 Jun; 75(17):1189-95. PubMed ID: 7778537
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein(B) identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients.
Wägner AM; Pérez A; Calvo F; Bonet R; Castellví A; Ordóñez J
Diabetes Care; 1999 May; 22(5):812-7. PubMed ID: 10332687
[TBL] [Abstract][Full Text] [Related]
3. Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Québec cardiovascular study.
Lamarche B; Després JP; Moorjani S; Cantin B; Dagenais GR; Lupien PJ
Atherosclerosis; 1996 Jan; 119(2):235-45. PubMed ID: 8808500
[TBL] [Abstract][Full Text] [Related]
4. Hyperinsulinemia as an independent risk factor for ischemic heart disease.
Després JP; Lamarche B; Mauriège P; Cantin B; Dagenais GR; Moorjani S; Lupien PJ
N Engl J Med; 1996 Apr; 334(15):952-7. PubMed ID: 8596596
[TBL] [Abstract][Full Text] [Related]
5. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study.
Lamarche B; Moorjani S; Lupien PJ; Cantin B; Bernard PM; Dagenais GR; Després JP
Circulation; 1996 Aug; 94(3):273-8. PubMed ID: 8759066
[TBL] [Abstract][Full Text] [Related]
7. A prospective, population-based study of low density lipoprotein particle size as a risk factor for ischemic heart disease in men.
Lamarche B; St-Pierre AC; Ruel IL; Cantin B; Dagenais GR; Després JP
Can J Cardiol; 2001 Aug; 17(8):859-65. PubMed ID: 11521128
[TBL] [Abstract][Full Text] [Related]
8. [Diabetic dyslipidemia and pathogenesis of ischemic heart disease].
Sokolov EI; Perova NV
Kardiologiia; 2003; 43(5):16-20. PubMed ID: 12891233
[TBL] [Abstract][Full Text] [Related]
9. [Apolipoproteins A-1 and B of the blood plasma and apolipoproteins A-1 of 2 high-density lipoprotein subclasses in ischemic heart disease patients with various lipoprotein spectra].
Metel'skaia VA; Perova NV; Chernysheva NP; Kurdanov KhA; Polesskiĭ VA
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(1):83-9. PubMed ID: 6407489
[TBL] [Abstract][Full Text] [Related]
10. Dyslipidemia in young Japanese children: its relation to familial hypercholesterolemia and familial combined hyperlipidemia.
Ohta T; Kiwaki K; Endo F; Umehashi H; Matsuda I
Pediatr Int; 2002 Dec; 44(6):602-7. PubMed ID: 12421255
[TBL] [Abstract][Full Text] [Related]
11. Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Québec Cardiovascular Study.
Pirro M; Mauriège P; Tchernof A; Cantin B; Dagenais GR; Després JP; Lamarche B
Atherosclerosis; 2002 Feb; 160(2):377-84. PubMed ID: 11849661
[TBL] [Abstract][Full Text] [Related]
12. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
13. [Changes in plasma lipid and apoprotein levels in patients with ischemic heart disease after hemosorption].
Ruzhanskaia TV; Perova NV; Kukharchuk VV; Rakhmedov DR; Kutsenko AI; Metel'skaia VA
Kardiologiia; 1992 Jan; 32(1):5-9. PubMed ID: 1614021
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients.
Kronenberg F; Lingenhel A; Neyer U; Lhotta K; König P; Auinger M; Wiesholzer M; Andersson H; Dieplinger H
Kidney Int Suppl; 2003 May; (84):S113-6. PubMed ID: 12694323
[TBL] [Abstract][Full Text] [Related]
15. [Impact of exercise on alimentary hyperlipoproteinemia in patients with ischemic heart disease].
Petrova NV; Bubnova MG; Aronov DM; Melkina OE; Olferév AM
Kardiologiia; 1992; 32(11-12):59-62. PubMed ID: 1297884
[TBL] [Abstract][Full Text] [Related]
16. Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction.
Hazzard WR; Goldstein JL; Schrott MG; Motulsky AG; Bierman EL
J Clin Invest; 1973 Jul; 52(7):1569-77. PubMed ID: 4352458
[TBL] [Abstract][Full Text] [Related]
17. Normal and gestational diabetic pregnancies. Lipids, lipoproteins and apolipoproteins.
de Arcos F; Castelo-Branco C; Casals E; Sanllehy C; Cararach V
J Reprod Med; 1998 Feb; 43(2):144-8. PubMed ID: 9513877
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men.
Clarke R; Emberson JR; Parish S; Palmer A; Shipley M; Linksted P; Sherliker P; Clark S; Armitage J; Fletcher A; Collins R
Arch Intern Med; 2007 Jul; 167(13):1373-8. PubMed ID: 17620530
[TBL] [Abstract][Full Text] [Related]
19. [Effect of micronized fenofibrate (lipantyl-200M) on synthesis of cholesterol in peripheral blood lymphocytes of patients with ischemic heart disease and hyperlipidemia].
Ivanova TN; Poliakova ED; Olfer'ev AM; Perova NV
Biull Eksp Biol Med; 1998 May; 125(5):569-73. PubMed ID: 9644562
[No Abstract] [Full Text] [Related]
20. Leptinemia is not a risk factor for ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study.
Couillard C; Lamarche B; Mauriège P; Cantin B; Dagenais GR; Moorjani S; Lupien PJ; Després JP
Diabetes Care; 1998 May; 21(5):782-6. PubMed ID: 9589240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
